US drugmaker KV Pharmaceutical is suing its former chief executive Marc Hermelin to avoid paying him a retirement and compensation …
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care

